About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
For more information, please visit www.thermofisher.com.
Teledyne API is a global leader in the design and manufacture of precision air quality and industrial gas monitoring instrumentation. These instruments are used worldwide in ambient air quality monitoring systems (AQMS), continuous emissions monitoring systems (CEMS) and industrial process applications. Our instruments are used by government monitoring agencies throughout the world for regulatory compliance, including ambient particulate / gas and stack gas emissions, as well as process control in industrial applications. Located in San Diego, California, USA, Teledyne API is part of the Environmental Instrumentation segment of Teledyne Technologies Incorporated (NYSE:TDY).
SICK is a leading global technology company for intelligent sensor solutions and integrated solutions in industrial automation. Innovative technologies set benchmarks and make industrial processes more efficient, safer, and more sustainable – in both logistics and manufacturing operations. Founded in 1946 by Dr. Erwin Sick and headquartered in Waldkirch near Freiburg, the company has a global presence with a network in around 40 countries. SICK has more than 10,000 employees worldwide and generated a group revenue of EUR 1.8 billion in the 2025 fiscal year. Further information: www.sick.com
Imprint: https://www.sick.com/imprint/